Needlescopic-assisted Uniportal vs Uniportal VATS

NCT03439696 — Not applicable, Completed, 110 participants, IRB of NTUH Hsin-Chu Branch

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Needlescopic-assisted Uniportal VATS Versus Conventional Uniportal VATS. A Randomized Prospective Noninferiority Study

RegistryNCT03439696, acronym UNeed
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment110 (Actual)
SponsorIRB of NTUH Hsin-Chu Branch (Other)
ConditionsLung Cancer, Lung Cancer Metastatic, Bullous Disease Lung, Nodule Solitary Pulmonary, Mediastinal Tumor
InterventionsThoracoscopic surgery (Procedure)
Datesstart 2018-02-22, primary completion 2018-12-12, completion 2019-04-30, first posted 2018-02-20, last updated 2021-02-25
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
All trials for Lung Cancer All trials for Lung Cancer Metastatic All trials of Thoracoscopic surgery

-Summary

The investigators' study aims is to evaluate the safety and efficacy of uniportal VATS under assistance of needlescopic instruments through additional 2-3 mm ports compared to conventional uniportal VATS in patients with lung lesions.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Needlescopic-assistedExperimentalProcedure: Thoracoscopic surgeryThoracoscopic surgery performed with the fashion of single 2.5-3.5 cm intercostal incision and 1-2 additional 2-3 mmm needlescopic ports.
UniportalActive comparatorProcedure: Thoracoscopic surgeryConventional uniportal VATS with single 2.5-3.5 cm intercostal incision
  • Thoracoscopic surgery (Procedure): Video-assisted thoracoscopic surgery for pulmonary or mediastinal lesions.

+Outcome measures

Primary outcomes

  • Pain scale POD 3 [3 days]: Post-operative day 3 pain scale documented using Visual Analogue Scale (VAS)
  • Pain scale POD 5 [5 days]: Post-operative day 5 pain scale documented using Visual Analogue Scale (VAS)
  • Hospital stay [14 days]: Post-operative hospital stay
  • Post-operative 3 month neuralgia [3 months]: Out patient documented using PainDETECT questionnaire (PD-Q)
  • Post-operative 6 month neuralgia [6 months]: Out patient documented using PainDETECT questionnaire (PD-Q)

Secondary outcomes

  • Cost [14 days]: Total hospital cost
  • Surgical time [1 day]: Time spend in surgery
  • Surgical bleeding [1 day]: Blood loss during operation
  • Opioid using dosage [14 days]: Total opioid equivalent dose used during post-operative course

+Eligibility

Sex: All, ages: 20 Years to 90 Years

Inclusion Criteria:

Lung or mediastinal disease requiring thoracoscopic surgery

Exclusion Criteria:

Thoracoscopic esophagectomy Decortication for empyema

+Locations (1)

FacilityCityCountryStatus
National Taiwan University Hospital, Hsin-Chu BranchTaipei, Hsin-Chu CountyTaiwan

+Investigators

  • Chiu-kuei Nien, Principal investigator, National Taiwan University Hospital Hsinchu Branch